Search results
Dec 8, 2021 · Health Canada has authorized Moderna's COVID-19 vaccine (also known as Spikevax) and Pfizer-BioNTech's vaccine (Comirnaty) for booster-shot use in people 18 or older. Both are mRNA vaccines.
NACI recommends that bivalent Omicron-containing mRNA COVID-19 vaccines are the preferred booster products for the authorized age groups. (Strong NACI recommendation) Moderna Spikevax BA.1 Bivalent (50 mcg) is authorized by Health Canada as a booster dose in individuals ≥18 years of age.
May 3, 2024 · Beginning in the fall of 2024, NACI recommends the following for the use of the most recently updated COVID-19 vaccines (only vaccines containing the latest selected strain should be used in fall 2024):
Nov 9, 2021 · Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine as a booster shot. A COVID-19 booster shot is an extra dose of the vaccine given after completion of the primary vaccine series.
Nov 9, 2021 · Health Canada has approved a booster of Pfizer-BioNTech's COVID-19 vaccine for people 18 years of age and older. The booster is intended to help people who've had their first two COVID-19...
Oct 29, 2021 · Booster shots should be given at least six months after the second dose of vaccine, NACI said. The boosters should also be one of the mRNA vaccines — Pfizer-BioNTech or Moderna, it said.
Nov 9, 2021 · Health Canada has approved a booster of Pfizer-BioNTech's COVID-19 vaccine for people over the age of 18, though third doses have already been given to high-risk people across the country.
